Artixio

Lifesciences Compliance Services In Mexico

From concept to commercialization, we assist in navigating the stringent regulatory process for life sciences products in Mexico.
Artixio is a preferred partner for the Lifesciences industry, including global brands, small-medium enterprises, and startups across pharmaceuticals, biotech, medical devices, diagnostics, cosmetics, nutraceuticals, animal feed, and veterinary. Our deep domain expertise, combined with our proven experience, is committed to providing you with seamless assistance throughout your regulatory journey. We provide regulatory intelligence-based based tailored solutions for COFEPRIS compliance and leverage your Life Sciences product and excel in its safety, quality, and marketing standards.

Ensure Seamless Regulatory Compliance In Mexico with Artixio

We at Artixio provide comprehensive services that include regulatory affairs, product registration, label, artwork, market access, post-market entry, and maintenance services, and many more in the life science sector in Mexico. Our customer-focused focused experienced regional team efficiently provides tailored solutions for your Life Sciences product compliance. Our tech-enabled team helps you expedite your product commercialization and help achieve sustained compliance in the Mexican market.

Regulatory Authorities In Mexico

COFEPRIS

SENASICA

Why Trust Artixio with Your Regulatory Journey In Mexico?

Expertise in Biopharmaceuticals, Devices, Cosmetics, Nutraceuticals, and Animal Health industries
ISO 9001:2015 certified quality assured team.
Proven experience in successfully registering and maintaining 2000+ licenses
Successful Approvals and Ongoing Product Lifecycle Maintenance for 200+ products.
Local specialized team with regulatory intelligence-based strategies in Mexico with proven experience of 15-30 years.
End-to-end support from product concept/prototype development, approval, and post-approval.
Customer-focused, Nimble, Flexible, and Detail-Oriented Team
Hybrid-Local-Centralized Support across Regulatory functions
KPI based, continual process excellence   

Our Services

Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access

Industries We Serve in the Mexico

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

FAQs

How to approach the regulatory bodies in Mexico, and what are the modes of communication?
The regulatory body in Mexico is COFEPRIS, and it can be approached by a legal representative or consultant. Primary communications can be done through emails, online portals, or in-person query requests.
COFEPRIS takes a period of 6-12 months for the approval of Life Sciences products. However, there are fast-track options for critical and pandemic novel drug approval.
The fees associated with the COFEPRIS in Mexico are approximately 450 to 3,000 USD for pharmaceuticals, 850 to 1,500 USD for medical devices, and 500 to $2,000 USD for veterinary products. The cosmetics products are generally exempt from the approval fees by COFEPRIS but may be subject to importation charges.
COFEPRIS has its adverse event reporting system known as the Pharmacovigilance Unit (UFV). The adverse event can be reported by the healthcare professionals or MAH through the UFV online portal or through their reporting forms.

Our Global Reach: Serving Life Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025